Glen Eagle Advisors’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
VPM
VCM
KBG
PMG
Glen Eagle Advisors's OGN Position: Q1 2026 in Review
Glen Eagle Advisors reduced its Organon & Co (OGN) stake by 65% in Q1 2026, selling an estimated $226 and leaving 16 shares worth $96. The position accounts for ﹤0.01% of the portfolio, ranked #1006.
Glen Eagle Advisors first reported a position in OGN in Q2 2021 and has held it in 20 quarters since. The position peaked at $24.1K in Q3 2021. 603 funds tracked by Wall St. Rank hold OGN as of Q1 2026.
- Glen Eagle Advisors held 16 shares of Organon & Co worth $96 as of Q1 2026.
- Glen Eagle Advisors sold 30 Organon & Co shares in Q1 2026, an estimated $226.
- Organon & Co made up ﹤0.01% of Glen Eagle Advisors's portfolio in Q1 2026, its #1006 holding.
- Glen Eagle Advisors first reported a position in Organon & Co in Q2 2021 and has held it in 20 quarters since.
- Glen Eagle Advisors's Organon & Co position peaked at $24.1K in Q3 2021.
- 603 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.
Based on Glen Eagle Advisors's 13F filing for Q1 2026, filed 15 May 2026.